ARCHIVES

ODAC Member Critical Of Amgen For Price Incentives.

This article is from The Cancer Letter archive.

Vol. 34 No. 11 | March 21, 2008

Download PDF Visit The Full Archive

Related Articles

CCOPs ask NCI officials about one-year extensions.

May 20, 2005

Prospects Fading for Funding More CCOPsIn FY ’83; Return to Groups Of Money From Satellites Going To New Programs

July 29, 1983

Agency Approves Two Pairs Of Drugs and Diagnostic Tests

September 30, 2011

American Association for Cancer Research Presents Awards at 2012 Annual Meeting

April 6, 2012

Francis Collins Nominated For NIH Director Two Days After Final Stem Cell Guidelines Released.

July 10, 2009

PET/CT Imaging During Treatment Shows Whether Chemo Is Working, Study Finds

April 24, 2009